← 홈

혈액암 (AML/ALL)

858개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 858개
AntibodystaleSpanish Lung Cancer GroupPreclinical

paclitaxel, carboplatin and bevacizumab (paclitaxel, carboplatin and bevacizumab)

Nonsquamous Nonsmall Cell Neoplasm of Lung · Nonsquamous Nonsmall Cell Neoplasm of Lu

#NonsquamousNonsmallCellNeoplasmo#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, pertuzumab + trastuzumab + docetaxel)

Non Small Cell Lung Cancer Metastatic; Non Small Cell Lung Cancer Stage III · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, pertuzumab + trastuzumab + nab-paclitaxel)

HER2+ Early or Locally Advanced Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
ADCBiologicstaleRochePhase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, pertuzumab, called T-DXd+P)

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleMemorial Sloan Kettering Cancer…Phase 2

pilimumab (pilimumab)

Advanced Stage Non-small Cell Lung Cancer · Advanced Stage Non-small Cell Lung Cance

#AdvancedStageNon-smallCellLungCa#Antibody#Phase2#항체#면역항체+2
효능 ORR 7%임상시험 1상태 ACTIVE
ADCBiologicstaleNew York Medical CollegePhase 1

pralatraxate, (pralatraxate,)

NK-Cell Lymphoma; NK-Cell Leukemia · NK-Cell Lymphoma

#NK-CellLymphoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleShenzhen Geno-Immune Medical In…Phase 1

prophylactic 4SCAR19 cells (prophylactic 4SCAR19 cells)

B Acute Lymphoblastic Leukemia · B Acute Lymphoblastic Leukemia

#BAcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleTianjin Medical University Canc…Phase 2

trastuzumab (Herceptin, pyrotinib + trastuzumab + nab-paclitaxel)

HER2+ Early or Locally Advanced Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

rituximab, methylprednisolone (rituximab, methylprednisolone)

Chronic B-Lymphocytic Leukemia · Chronic B-Lymphocytic Leukemia

#ChronicB-LymphocyticLeukemia#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 3

sac-TMT (sac-TMT)

Non-small Cell Lung Cancer; NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleThe First Affiliated Hospital o…Phase 2

ssCART-19 cells combined with CD19+ feeding T cells (FTCs, ssCART-19 cells combined with CD19+ feeding T cells, ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion)

Acute Lymphoblastic Leukemia, Adult B-Cell · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

Almonertinib/Furmonertinib/Osimertinib (third-generation EGFR TKIs, third-generation EGFR TKIs (Almonertinib/Furmonertinib/Osimertinib))

Non Small Cell Lung Cancer; ERBB2 Mutation-Related Tumors · EGFR

#EGFR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

toripalimab + cetuximab + platinum (three cycles, three cycles (toripalimab + cetuximab + platinum))

Locally Advanced Hypopharyngeal Carcinoma · Locally Advanced Hypopharyngeal Carcinom

#LocallyAdvancedHypopharyngealCar#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAstraZenecaPhase 3

anti-CTLA4 (tremelimumab, tremelimumab (anti-CTLA4))

Non - Small Cell Lung Cancer NSCLC · Non - Small Cell Lung Cancer NSCLC

#Non-SmallCellLungCancerNSCLC#Antibody#Phase3#항체#면역항체+2
효능 ORR 35.5%임상시험 1상태 ACTIVE
CGTBiologicstaleInstitute of Hematology & Blood…Phase 1

uCD7 CART (uCD7 CART)

Acute Myeloid Leukemia (AML); T Lymphoblastic Leukemia/Lymphoma · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleMingfeng ZhaoPhase 1

universal CLL1 CAR-T cells (universal CLL1 CAR-T cells)

Acute Myeloid Leukemia; Chimeric Antigen Receptor T-cell · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleChangzhou No.2 People's HospitalPhase 1

universal allogeneic anti-CD19/BCMA CAR T-cells (universal allogeneic anti-CD19/BCMA CAR T-cells)

Systemic Lupus Erythematosus; Autoimmune Hemolytic Anemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleSichuan UniversityPhase 1

BHP01 (α-PD-L1/4-1BB DLL3 CAR-T, α-PD-L1/4-1BB DLL3 CAR-T (BHP01))

Small Cell Lung Cancer Extensive Stage · PD-L1

#PD-L1#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING

43 / 43 페이지

← 이전다음 →